GoodRx Holdings (GDRX) Gross Profit (2019 - 2026)

GoodRx Holdings has disclosed Gross Profit across 8 years of filings, most recently posting $113.0 million for Q1 2026.

• Gross Profit for Q1 2026 came in at $113.0 million, down 4.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $733.8 million (up 165.25% YoY), and the FY2025 annual result was $739.3 million, up 73.86% from the prior year.
• Gross Profit came in at $113.0 million for Q1 2026 at GoodRx Holdings, down from $390.1 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $390.1 million in Q4 2025 to a low of -$132.5 million in Q4 2024.
• The 5-year median for Gross Profit is $112.5 million (2025), against an average of $102.0 million.
• Across the five-year window, Gross Profit plunged 44.8% in 2023 and jumped 394.42% in 2025, its largest moves.
• GoodRx Holdings' Gross Profit stood at -$125.8 million in 2022, then grew by 26.13% to -$92.9 million in 2023, then tumbled by 42.59% to -$132.5 million in 2024, then surged by 394.42% to $390.1 million in 2025, then tumbled by 71.05% to $113.0 million in 2026.
• The last three Gross Profit figures came in at $113.0 million (Q1 2026), $390.1 million (Q4 2025), and $112.5 million (Q3 2025), per Business Quant data.